GlassScriptPhysician profile
Mario Haddad
NPI 1750386652
$3,899.78
in general payments reported to CMS, 2019-2025
16 companies · $199 in 2025
The $199 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $506 · 2020: $599 · 2021: $1,153 · 2022: $599 · 2023: $559 · 2024: $285 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,042.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $794.34 | 2019-2024 | Farxiga, Lokelma |
| Janssen Pharmaceuticals, INC | $624.06 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $523.90 | 2019-2024 | Jardiance, Tradjenta |
| Pbg Puerto Rico LLC | $407.57 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $320.00 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $284.86 | 2021-2024 | Eliquis |
| Merck Sharp & Dohme LLC | $262.93 | 2019-2024 | Janumet, Steglatro, Januvia |
| Endologix LLC | $173.59 | 2025 | Endocross Device, Torus Stent Graft System |
| Eli Lilly Export S.A. Puerto Rico Branch | $164.23 | 2020-2022 | |
| Glaxosmithkline, LLC. | $138.67 | 2019-2021 | |
| Pfizer Pharmaceuticals LLC | $57.20 | 2019 | |
| Exact Sciences Corporation | $50.00 | 2024 | Cologuard Collection Kit |
| Novo Nordisk INC | $25.00 | 2022 | |
| Dexcom, INC. | $25.00 | 2025 | Dexcom G6 Transmitter |
| Biotronik INC. | $24.48 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $23.95 | 2024 | Phasix Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Haddad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.